Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Yerushalmi, R
  • Dong, B
  • Chapman, JW
  • Goss, PE
  • Pollak, MN
  • Burnell, MJ
  • Bramwell, VH
  • Levine, Mark Norman
  • Pritchard, KI
  • Whelan, Timothy
  • Ingle, JN
  • Parulekar, W
  • Shepherd, LE
  • Gelmon, KA

publication date

  • May 20, 2011